Skip to main content
. 2006 Dec 18;150(2):176–185. doi: 10.1038/sj.bjp.0706975

Figure 6.

Figure 6

Effects of i.pl. injection of PAR4-activating peptide (PAR4-AP) or control peptide (50 μg per paw) observed at 6-h time point on inflammatory parameters: paw oedema (a) and MPO activity (b). Each column represents the mean and vertical lines show s.e.m. (n=8 rats per group).